july, 2021

Time
(Wednesday) 10:00 am - 11:00 am
Location
Online
Virtual Event Details
Event has already taken place!
Click here to watch recorded event.
Click here to watch recorded event.
Registration
Registration is closed at this time.
Topic
Key Discussion Points:
- Key lessons from the pandemic & the fundamental changes this event has wrought upon your industry and organisation
- Key challenges for the industry in 2021
- Addressing the rising demand for generics in the international markets
- Indian companies have invested a lot in research capabilities. Strengthening this critical area
- Indian and global pharma companies collaborating to bring greater benefits to patients, especially in critical illnesses
- The power of digital technologies is most effective in the research and production of medicine. Discussion on technology investment plans going ahead
Speakers
- Deepak Sapra CEO, API & Services, Dr. Reddy’s
- Vivek V. Kamath Managing Director & General Manager, Specialty Care, Pharmaceuticals, Abbott India
- Ramesh Swaminathan CFO and Head Corporate Affairs, Lupin
- Venugopal Vijayendran President India Business, Intas Pharma
- Dr. Vikas Gupta India Business Head, Cipla
- Rishabh Bindlish Managing Director, India Life Sciences and Global Generics Lead, Accenture
- Alokesh Bhattacharyya (Moderator) Senior Editor, The Economic Times
Organizer
Timestreamtimestream@timesgroup.com